A detailed history of Convergence Financial, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Convergence Financial, LLC holds 8,098 shares of PFE stock, worth $194,109. This represents 0.04% of its overall portfolio holdings.

Number of Shares
8,098
Previous 9,092 10.93%
Holding current value
$194,109
Previous $241 Million 14.93%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 24, 2025

SELL
$25.01 - $27.13 $24,859 - $26,967
-994 Reduced 10.93%
8,098 $205 Million
Q4 2024

Feb 04, 2025

SELL
$24.8 - $30.19 $44,888 - $54,643
-1,810 Reduced 16.6%
9,092 $241 Million
Q3 2024

Oct 23, 2024

SELL
$27.7 - $31.39 $176,476 - $199,985
-6,371 Reduced 36.88%
10,902 $316 Million
Q2 2024

Oct 23, 2024

BUY
$25.26 - $29.6 $436,315 - $511,280
17,273 New
17,273 $483 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $135B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Convergence Financial, LLC Portfolio

Follow Convergence Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Financial, LLC with notifications on news.